Skip to main content

Characterization of COVID-19 Vaccinations: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
COVID-19 vaccines
Description

In this analysis, we counted and described individuals with evidence of coronavirus disease 2019 (COVID-19) vaccinations. We identified individuals with at least one COVID-19 vaccination and calculated the timing between doses, overall and by brand. We additionally identified individuals with at least two COVID-19 vaccinations and characterized the timing between doses. We finally identified individuals with evidence of a booster COVID-19 vaccination.

This analysis contains two reports:

  • Report 1: This report was distributed to six Rapid Sentinel Database Data Partners on May 17, 2024. The study period includes data from November 1, 2020 to February 29, 2024.
  • Report 2: This report was distributed to 14 Sentinel Data Partners on May 17, 2024. The study period includes data from November 1, 2020 to January 31, 2024. 
Deliverables (2)
Sentinel Modular Program Report: Characterization of COVID-19 Vaccinations: A Descriptive Analysis, Report 1 Sentinel Modular Program Report: Characterization of COVID-19 Vaccinations: A Descriptive Analysis, Report 2
Additional Details
FDA Center
CDER
Time Period
November 1, 2020 - February 29, 2024; November 1, 2020 - January 31, 2024
Analysis Type
Descriptive
Population / Cohort
All Individuals
Data Sources
Rapid Sentinel Distributed Database (SDD); Sentinel Distributed Database (SDD)
Related Links
Sentinel Methods Project: Characterization of COVID-19 Vaccination Data in the SDD
Presentation: Characterization of COVID-19 Vaccine Data in the Sentinel System